×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| NATURAL CAPSULES LTD. | 455.62 | -55.8 | 452.03 | -5.4 | 281.0 | 36.2 |
| Nureca Limited | 369.16 | 5.52 | 343.24 | 0.55 | 278 | |
| GENNEX LABORATORIES LTD. | 364.55 | 50.16 | 341.78 | 0.21 | 269 | 16.3 |
Natural Capsules Ltd., with Security Code 524654, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45.5 | 38.1 | 37.7 | 37.5 | 38.4 | 40.2 | 39.1 | 41.0 | 43.4 | 44.4 |
| Expenses | 35.8 | 31.2 | 31.6 | 32.3 | 33.4 | 35.7 | 34.4 | 36.1 | 38.8 | 39.2 |
| Operating Profit | 9.7 | 6.9 | 6.1 | 5.3 | 4.9 | 4.5 | 4.7 | 4.9 | 4.6 | 5.1 |
| OPM % | 21.32% | 18.05% | 16.1% | 13.99% | 12.87% | 11.22% | 12.08% | 12.05% | 10.56% | 11.56% |
| Other Income | 0.0 | 0.8 | 0.6 | 0.6 | 0.7 | 1.3 | 0.8 | 0.8 | 1.2 | 1.5 |
| Interest | 1.0 | 1.3 | 1.2 | 1.2 | 1.2 | 1.4 | 1.5 | 1.5 | 1.4 | 1.5 |
| Depreciation | 1.7 | 1.9 | 2.1 | 2.2 | 2.2 | 2.1 | 2.1 | 2.2 | 2.1 | 1.9 |
| Profit before tax | 7.0 | 4.6 | 3.3 | 2.5 | 2.3 | 2.3 | 1.9 | 2.0 | 2.2 | 3.2 |
| Tax % | -25.2% | -26.3% | -26.1% | -22.4% | -25.8% | -24.9% | -24.7% | -54.2% | -23% | -16% |
| Net Profit | 5.3 | 3.4 | 2.5 | 2.0 | 1.7 | 1.7 | 1.5 | 0.9 | 1.7 | 2.6 |
| EPS in Rs | 5.68 | 2.64 | 2.11 | 1.82 | 2.09 | 1.56 | 0.9 | 1.65 | 0 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.6 | 37.7 | 37.5 | 40.0 | 40.2 | 39.2 | 41.2 | 43.8 | 45.0 | 45.2 |
| Expenses | 31.0 | 31.7 | 32.4 | 35.3 | 36.1 | 34.8 | 36.7 | 39.6 | 40.5 | 44.9 |
| Operating Profit | 6.6 | 6.0 | 5.1 | 4.7 | 4.1 | 4.4 | 4.5 | 4.3 | 4.5 | 0.3 |
| OPM % | 17.62% | 15.81% | 13.65% | 11.83% | 10.22% | 11.13% | 10.93% | 9.73% | 9.93% | 0.71% |
| Other Income | 0.2 | 0.2 | 0.4 | 0.5 | 0.9 | 0.2 | 0.1 | 0.1 | 0.3 | 0.4 |
| Interest | 1.1 | 1.3 | 1.2 | 1.2 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 2.5 |
| Depreciation | 1.9 | 2.1 | 2.2 | 2.2 | 2.2 | 2.3 | 2.3 | 2.3 | 2.2 | 4.2 |
| Profit before tax | 3.9 | 2.7 | 2.1 | 1.8 | 1.4 | 0.8 | 0.6 | 0.5 | 1.0 | -6.1 |
| Tax % | -31.1% | -32.3% | -27.1% | -32.8% | -32.2% | -22.1% | -199.4% | -79.1% | -33.7% | 8% |
| Net Profit | 2.7 | 1.8 | 1.6 | 1.2 | 1.0 | 0.6 | -0.6 | 0.1 | 0.5 | -5.6 |
| EPS in Rs | 2.8 | 1.96 | 1.67 | 1.29 | 1.31 | 0.65 | -0.6 | 0.1 | 0 | -5.4 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 21% |
| 3 Years: | 25% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 30% |
| 3 Years: | 14% |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 42% |
| 3 Years: | -24% |
| 1 Year: | -35% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 25% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 2% |
| TTM: | -83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 42% |
| 3 Years: | -24% |
| 1 Year: | -35% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|